Cybin Cash from 2010 to 2024

CYBN Stock  USD 10.64  0.82  8.35%   
Check Cybin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cybin's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cybin financial statements analysis is a perfect complement when working with Cybin Valuation or Volatility modules.
  
Check out the analysis of Cybin Correlation against competitors.

About Cybin Financial Statements

Cybin investors utilize fundamental indicators, such as Cash, to predict how Cybin Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. It has also developed EMBARK, a psychedelic-assisted psychotherapy. Cybin operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 50 people.

Pair Trading with Cybin

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cybin position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cybin will appreciate offsetting losses from the drop in the long position's value.

Moving against Cybin Stock

  0.69NKTX Nkarta IncPairCorr
  0.67MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.63ME 23Andme HoldingPairCorr
  0.63MTEM Molecular TemplatesPairCorr
  0.63TPST Tempest TherapeuticsPairCorr
The ability to find closely correlated positions to Cybin could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cybin when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cybin - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cybin Inc to buy it.
The correlation of Cybin is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cybin moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cybin Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cybin can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cybin Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cybin's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cybin Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cybin Inc Stock:
Check out the analysis of Cybin Correlation against competitors.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cybin. If investors know Cybin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cybin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cybin Inc is measured differently than its book value, which is the value of Cybin that is recorded on the company's balance sheet. Investors also form their own opinion of Cybin's value that differs from its market value or its book value, called intrinsic value, which is Cybin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cybin's market value can be influenced by many factors that don't directly affect Cybin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cybin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cybin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cybin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.